In this issue:
PRESTO: apalutamide + ADT beneficial in high-risk biochemically recurrent disease
Salvage therapy for prostate cancer: AUA/ASTRO/SUO Guideline
Part 1: decisions at suspected biochemical recurrence
Part 2: treatment of non-metastatic biochemical recurrence
Part 3: salvage therapy after radiotherapy, regional recurrence, and oligometastasis
WARMTH Act: later-line 225Ac-PSMA radioligand therapy may be effective in mCRPC
Plant-based diet linked to better quality of life
Dose-escalated radiotherapy + ADT improves survival in high-risk localised prostate cancer
T-cell engager HPN328 active in neuroendocrine prostate cancer
Clinicians responsible for low rates of prostate cancer screening in transgender women
Could physical activity reduce the risk of developing prostate cancer
Registration open for 2024 MOGA annual scientific meeting
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)